Grupo para la caracterización molecular de las neoplasias hematológicas
University of Ulm
Ulm, AlemaniaPublications in collaboration with researchers from University of Ulm (2)
2014
-
Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions
New England Journal of Medicine, Vol. 370, Núm. 12, pp. 1101-1110